论文部分内容阅读
目的:观察双歧杆菌四联活菌片联合参苓白术汤治疗肝硬化非感染性腹泻的临床疗效。方法:将肝硬化非感染性腹泻患者92例随机2组各46例。西医组予以双歧杆菌四联活菌片治疗,联合纽在西医组治疗基础上加用参苓白术汤口服,2组疗程均为6周。观察2组患者治疗期间大便性状及次数,测定肝功能指标。结果:治疗后,2组患者肝功能指标均有不同程度下降(P<0.05,P<0.01),联合组改善优于西医组(P<0.05)。治疗后,总有效率联合组为93.48%,西医组为76.09%,2组比较,差异有显著性意义(P<0.05)、结论:双歧杆菌四联活菌片联合参苓白术汤治疗肝硬化非感染性腹泻的疗效显著,并能改善患者肝功能。
Objective: To observe the clinical efficacy of Bifidobacterium quadricepsil in combination with Shenling Baizhu Decoction in the treatment of non-infectious cirrhosis with diarrhea. Methods: Forty-two patients with cirrhosis and non-infectious diarrhea were randomly divided into two groups (n = 46). Western medicine group to Bifidobacterium quadruple live bacteria tablets treatment, joint New Zealand on the basis of Western medicine group plus oral Shenling Baizhu Tang, two groups of treatment were 6 weeks. Stool traits and times during the treatment were observed in 2 groups, and liver function indexes were measured. Results: After treatment, the indexes of liver function decreased in both groups (P <0.05, P <0.01), and the improvement in combination group was better than that in Western medicine group (P <0.05). After treatment, the total effective rate was 93.48% in the combination group and 76.09% in the Western medicine group. There was significant difference between the two groups (P <0.05). Conclusion: The combination of Bifidobacterium quadricepsis and Shenling Baizhu decoction Hardening non-infectious diarrhea significant effect, and can improve liver function in patients.